Hemispherx Biopharma Inc (NYSE American:HEB)

0.355
Delayed Data
As of Apr 20
 -0.025 / -6.58%
Today’s Change
0.30
Today|||52-Week Range
0.84
+2.60%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Revenue and IncomeNet Revenues84.0K213.0K90.0K50.0K
 
 
 
 
 
Cost of Goods Sold133.0K94.5K133.0K79.0K
 
 
 
 
 
Depreciation And Amortization274.0K247.0K266.0K217.0K
 
 
 
 
 
 
Operating ExpensesGross Income-323.0K-128.5K-309.0K-246.0K
 
 
 
 
 
General Expenses2.9M2.6M2.3M2.5M
 
 
 
 
 
Research And Development1.4M1.1M787.0K814.0K
 
 
 
 
 
Total Operating Expenses3.3M2.9M2.7M2.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-3.2M-2.7M-2.7M-2.8M
 
 
 
 
 
Extraordinary Credit393.0K529.0K1.4M56.0K
 
 
 
 
 
Interest Expense On Debt0.0019.0K51.0K69.0K
 
 
 
 
Other Expenses1.0K6.0K0.00785.0K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-2.8M-2.2M-1.3M-2.0M
 
 
 
 
 
Net Income-2.8M-2.2M-1.3M-2.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS25.3M27.3M30.1M32.9M
 
 
 
 
 
Shares To Calculate EPS Diluted25.3M27.3M30.1M32.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.11-$0.08-$0.04-$0.06
 
 
 
 
 
EPS Diluted-$0.11-$0.08-$0.04-$0.06